MEDIA
Latest News
Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.
Main Menu
- 10 February 2023
Often Lasting Twice as Long as Any Other Neurotoxin on the Market, Daxxify Makes Its US Debut
- 26 September 2022
Two New Studies Highlight the Efficacy and Safety Profile of Revance’s DAXXIFY
- 23 September 2022